Open AccessMALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer
Author(s) -
Xueqi Ou,
Guanfeng Gao,
Meiheban Bazhabayi,
Kaiming Zhang,
Feng Li,
Xia Xiao
Publication year - 2019
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_282_19
Subject(s) - malat1 , immunohistochemistry , triple negative breast cancer , tissue microarray , pathological , oncology , breast cancer , adenocarcinoma , medicine , stage (stratigraphy) , survival analysis , correlation , clinical significance , pathology , cancer , biology , gene , downregulation and upregulation , paleontology , biochemistry , geometry , mathematics , long non coding rna
The purpose of this study was to investigate the potential correlation between metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and the transcription factor BTB and CNC homology 1 (BACH1) and their clinicopathological significance in triple-negative breast cancer (TNBC).